- Report
- August 2025
- 195 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 189 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 183 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- April 2025
- 250 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- April 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- September 2025
- 380 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 563 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 276 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 375 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 376 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 274 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 170 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 475 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- August 2025
- 193 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 180 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- January 2025
- 180 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- May 2025
- 120 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- December 2024
- 200 Pages
Global
From €3309EUR$3,750USD£2,862GBP

DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more